Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “The Primary Study Objective is to Assess the Efficacy and”

2 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 2 of 2 results

Post-approval studies (Phase 4)Study completedNCT00844194
What this trial is testing

Duloxetine in Patients With Diabetic in Peripheral Neuropathic Pain With or Without Co-morbid Major Depressive Disorder

Who this might be right for
Diabetic NeuropathiesDepressive Disorder, Major
Boehringer Ingelheim 108
Large-scale testing (Phase 3)UnknownNCT01589146
What this trial is testing

ONE WEEK VERSUS FOUR WEEK HEPARIN PROPHYLAXIS AFTER LAPAROSCOPIC SURGERY FOR COLORECTAL CANCER.

Who this might be right for
The Primary Study Objective is to Assess the Efficacy andSafety of Extended 4-week Heparin Prophylaxis Compared toProphylaxis Given for 8±2 Days After Planned Laparoscopic+4 more
University Of Perugia 400